Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19
Texas Heart Institute Journal · 2024
DOI: 10.14503/thij-23-8309 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Texas Heart Institute Journal, 2024. Verfasst von Pengyang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia. Hauptthemen laut MEDLINE: COVID-19, Takotsubo Cardiomyopathy, Hospitalization, Hospital Mortality. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Takotsubo syndrome has been reported in patients with COVID-19, although minimal data are available. This investigation assessed the incidence and impact of takotsubo syndrome on patients hospitalized with COVID-19.
Methods
A retrospective cohort study was conducted using International Statistical Classification of Diseases, Tenth Revision, codes to identify patients with a primary diagnosis of COVID-19 with or without takotsubo syndrome in the National Inpatient Sample 2020 database. Outcomes between groups were compared after propensity score matching for patient and hospital demographics and comorbidities.
Results
A total of 211,448 patients with a primary diagnosis of COVID-19 were identified. Of these, 171 (0.08%) had a secondary diagnosis of takotsubo syndrome. Before matching, patients with COVID-19 and takotsubo syndrome, compared with patients without takotsubo syndrome, were older (68.95 vs 64.26 years; P < .001); more likely to be female (64.3% vs 47.2%; P < .001); and more likely to have anxiety (24.6% vs 12.8%; P < .001), depression (17.5% vs 11.4%; P = .02), and chronic obstructive pulmonary disease (24.6% vs 14.7%; P < .001). The takotsubo syndrome group had worse outcomes than the non–takotsubo syndrome group for death (30.4% vs 11.1%), cardiac arrest (7.6% vs 2.1%), cardiogenic shock (12.9% vs 0.4%), length of hospital stay (10.7 vs 7.5 days), and total charges ($152,685 vs $78,468) (all P < .001). After matching and compared with the non–takotsubo syndrome group (n = 508), the takotsubo syndrome group (n = 170) had a higher incidence of inpatient mortality (30% vs 14%; P < .001), cardiac arrest (7.6% vs 2.8%; P = .009), and cardiogenic shock (12.4% vs 0.4%; P < .001); a longer hospital stay (10.7 vs 7.6 days; P < .001); and higher total charges ($152,943 vs $79,523; P < .001).
Conclusion
Takotsubo syndrome is a rare but severe in-hospital complication in patients with COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.
- Faculty of Medicine, St George's, University of London, London, United Kingdom.
- Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong Province, China.
- Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, Massachusetts.
- Division of Cardiology, Department of Medicine, University of Texas at San Antonio, San Antonio, Texas.
- Department of Medicine, Eastern Carolina University Health Medical Center, Greenville, North Carolina.
Zitieren
APA
Li, P., Shi, A., Lu, X., Li, C., Cai, P., Teng, C., Wu, L., Shu, Y., Pan, S., Dixon, R. A. F., Liu, Q., & Wang, B. (2024). Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19. Texas Heart Institute Journal. https://doi.org/10.14503/thij-23-8309
Vancouver
Li P, Shi A, Lu X, Li C, Cai P, Teng C, et al. Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19. Texas Heart Institute Journal. 2024. doi:10.14503/thij-23-8309
BibTeX
@article{Li2024,
author = {Li, Pengyang and Shi, Ao and Lu, Xiaojia and Li, Chenlin and Cai, Peng and Teng, Catherine and Wu, Lingling and Shu, Yuan and Pan, Su and Dixon, Richard A F and Liu, Qi and Wang, Bin},
title = {Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19},
journal = {Texas Heart Institute Journal},
year = {2024},
doi = {10.14503/thij-23-8309}
}
EUVIMED